Table 3.
Antibiotic-bacterial isolate relationship through the VITEK 2 (bioMerieux) compact system.
| Antibiotics | MIC (μg/mL) | Interpretation |
|---|---|---|
| Ticarcillin/Clavulanic acid | 8.00 ± 0.06 | S |
| Piperacillin/Tazobactam | – | – |
| Ceftazidime | 1.03 ± 0.09 | S |
| Cefoperazone/Sulbactam | 8.10 ± 0.06 | S |
| Cefepime | 1.07 ± 0.09 | S |
| Aztreonam | 1.03 ± 0.04 | S |
| Doripenem | 0.12 ± 0.003 | S |
| Imlpenem | – | – |
| Meropenem | 0.25 ± 0.005 | S |
| Amikacin | 2.03 ± 0.03 | S |
| Gentamicin | 1.17 ± 0.17 | S |
| Ciprofloxacin | 0.25 ± 0.003 | S |
| Levofloxacin | 0.12 ± 0.003 | S |
| Minocycline | 2.16 ± 0.17 | S |
| Tigecycline | 1.03 ± 0.03 | S |
| Colistin | <16.03 ± 0.03 | R |
| Trimethoprim/Sulfamethoxazole | 20 ± 0.03 | S |
R, resistant; I, intermediate; S, susceptible; -, Not detected.